| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
|
|
ACOT7
|
acyl-CoA thioesterase 7
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFAP1L2
|
actin filament associated protein 1-like 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGRP
|
agouti related neuropeptide
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTPBP1
|
ATP/GTP binding protein 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIM2
|
absent in melanoma 2
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKR1E2
|
aldo-keto reductase family 1, member E2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH8
|
alkB, alkylation repair homolog 8 (E. coli)
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ANGPT1
|
angiopoietin 1
|
|
ANKRD11
|
ankyrin repeat domain 11
|
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle)
|
|
ANKRD6
|
ankyrin repeat domain 6
|
|
ANXA2
|
annexin A2
|
|
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit
|
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
|
AP3M1
|
adaptor-related protein complex 3, mu 1 subunit
|
|
AP4M1
|
adaptor-related protein complex 4, mu 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
|
|
ARF4
|
ADP-ribosylation factor 4
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARRB1
|
arrestin, beta 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATF6
|
activating transcription factor 6
|
|
ATG13
|
autophagy related 13
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN3
|
ataxin 3
|
|
AUP1
|
ancient ubiquitous protein 1
|
|
AURKA
|
aurora kinase A
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAG4
|
BCL2-associated athanogene 4
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BLVRA
|
biliverdin reductase A
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C3
|
complement component 3
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CAPN10
|
calpain 10
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD34
|
CD34 molecule
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD48
|
CD48 molecule
|
|
CD70
|
CD70 molecule
|
|
CD81
|
CD81 molecule
|
|
CD86
|
CD86 molecule
|
|
CD9
|
CD9 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDC6
|
cell division cycle 6
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPA
|
centromere protein A
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHMP1A
|
charged multivesicular body protein 1A
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal)
|
|
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle)
|
|
CHRND
|
cholinergic receptor, nicotinic, delta (muscle)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN1
|
claudin 1
|
|
CLDN4
|
claudin 4
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC4E
|
C-type lectin domain family 4, member E
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
CMYA5
|
cardiomyopathy associated 5
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COG8
|
component of oligomeric golgi complex 8
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL9A1
|
collagen, type IX, alpha 1
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNNBL1
|
catenin, beta like 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYC1
|
cytochrome c-1
|
|
CYTIP
|
cytohesin 1 interacting protein
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DAXX
|
death-domain associated protein
|
|
DCN
|
decorin
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB1
|
defensin, beta 1
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DHX33
|
DEAH (Asp-Glu-Ala-His) box polypeptide 33
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DLG5
|
discs, large homolog 5 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DLX1
|
distal-less homeobox 1
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DOCK3
|
dedicator of cytokinesis 3
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DUOX1
|
dual oxidase 1
|
|
DUX1
|
double homeobox 1
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EMD
|
emerin
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB4
|
EPH receptor B4
|
|
EPHB6
|
EPH receptor B6
|
|
EPN1
|
epsin 1
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETF1
|
eukaryotic translation termination factor 1
|
|
ETV6
|
ets variant 6
|
|
EXO1
|
exonuclease 1
|
|
EXOC6
|
exocyst complex component 6
|
|
EZR
|
ezrin
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FA2H
|
fatty acid 2-hydroxylase
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FBXO32
|
F-box protein 32
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGG
|
fibrinogen gamma chain
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FN1
|
fibronectin 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXA2
|
forkhead box A2
|
|
FOXC1
|
forkhead box C1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXP3
|
forkhead box P3
|
|
FOXP4
|
forkhead box P4
|
|
FPR1
|
formyl peptide receptor 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FUS
|
FUS RNA binding protein
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
FXR2
|
fragile X mental retardation, autosomal homolog 2
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA3
|
GATA binding protein 3
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3
|
|
GH1
|
growth hormone 1
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GKN1
|
gastrokine 1
|
|
GLB1
|
galactosidase, beta 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNAT3
|
guanine nucleotide binding protein, alpha transducing 3
|
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GPR55
|
G protein-coupled receptor 55
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HCAR3
|
hydroxycarboxylic acid receptor 3
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HDAC4
|
histone deacetylase 4
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HK1
|
hexokinase 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HOXA4
|
homeobox A4
|
|
HOXA5
|
homeobox A5
|
|
HOXB13
|
homeobox B13
|
|
HOXB4
|
homeobox B4
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IER3
|
immediate early response 3
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL31RA
|
interleukin 31 receptor A
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9R
|
interleukin 9 receptor
|
|
ILK
|
integrin-linked kinase
|
|
INHBA
|
inhibin, beta A
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRS4
|
insulin receptor substrate 4
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITPKA
|
inositol-trisphosphate 3-kinase A
|
|
ITPKB
|
inositol-trisphosphate 3-kinase B
|
|
ITPKC
|
inositol-trisphosphate 3-kinase C
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNG1
|
kininogen 1
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT14
|
keratin 14, type I
|
|
KSR2
|
kinase suppressor of ras 2
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAT
|
linker for activation of T cells
|
|
LAT2
|
linker for activation of T cells family, member 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LEP
|
leptin
|
|
LETM1
|
leucine zipper-EF-hand containing transmembrane protein 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIMK2
|
LIM domain kinase 2
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMAN2L
|
lectin, mannose-binding 2-like
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
LRRFIP2
|
leucine rich repeat (in FLII) interacting protein 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LUC7L3
|
LUC7-like 3 (S. cerevisiae)
|
|
LY96
|
lymphocyte antigen 96
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYPLA1
|
lysophospholipase I
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC5R
|
melanocortin 5 receptor
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCM9
|
minichromosome maintenance complex component 9
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MID1
|
midline 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR142
|
microRNA 142
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR20A
|
microRNA 20a
|
|
MIR25
|
microRNA 25
|
|
MIR34A
|
microRNA 34a
|
|
MIR494
|
microRNA 494
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTBP
|
MDM2 binding protein
|
|
MTCH1
|
mitochondrial carrier 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYBPH
|
myosin binding protein H
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYLK
|
myosin light chain kinase
|
|
MYO1C
|
myosin IC
|
|
MYOD1
|
myogenic differentiation 1
|
|
NANOG
|
Nanog homeobox
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NIN
|
ninein (GSK3B interacting protein)
|
|
NKX3-2
|
NK3 homeobox 2
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUDT21
|
nudix (nucleoside diphosphate linked moiety X)-type motif 21
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OCLN
|
occludin
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORM1
|
orosomucoid 1
|
|
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin
|
|
OSBP
|
oxysterol binding protein
|
|
OSM
|
oncostatin M
|
|
OSR1
|
odd-skipped related transciption factor 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PANX1
|
pannexin 1
|
|
PAPSS1
|
3'-phosphoadenosine 5'-phosphosulfate synthase 1
|
|
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD6
|
programmed cell death 6
|
|
PDF
|
peptide deformylase (mitochondrial)
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEAR1
|
platelet endothelial aggregation receptor 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PEX19
|
peroxisomal biogenesis factor 19
|
|
PGR
|
progesterone receptor
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN1
|
protein kinase N1
|
|
PKN2
|
protein kinase N2
|
|
PKN3
|
protein kinase N3
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLK1
|
polo-like kinase 1
|
|
PLXND1
|
plexin D1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POMC
|
proopiomelanocortin
|
|
PON3
|
paraoxonase 3
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPRC1
|
peroxisome proliferator-activated receptor gamma, coactivator-related 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD2
|
protein kinase D2
|
|
PRL
|
prolactin
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROX1
|
prospero homeobox 1
|
|
PSEN1
|
presenilin 1
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTN
|
pleiotrophin
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAI1
|
retinoic acid induced 1
|
|
RALGDS
|
ral guanine nucleotide dissociation stimulator
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBM4
|
RNA binding motif protein 4
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RECQL4
|
RecQ protein-like 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
RER1
|
retention in endoplasmic reticulum sorting receptor 1
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS3
|
regulator of G-protein signaling 3
|
|
RHBDF1
|
rhomboid 5 homolog 1 (Drosophila)
|
|
RHOA
|
ras homolog family member A
|
|
RHOG
|
ras homolog family member G
|
|
RHOH
|
ras homolog family member H
|
|
RHOU
|
ras homolog family member U
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIN3
|
Ras and Rab interactor 3
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RNF43
|
ring finger protein 43
|
|
RNU1-1
|
RNA, U1 small nuclear 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RORB
|
RAR-related orphan receptor B
|
|
RPS2
|
ribosomal protein S2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAA1
|
serum amyloid A1
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1
|
|
SDC1
|
syndecan 1
|
|
SDC3
|
syndecan 3
|
|
SDC4
|
syndecan 4
|
|
SELE
|
selectin E
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMG2
|
semenogelin II
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3BP1
|
SH3-domain binding protein 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC46A2
|
solute carrier family 46, member 2
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC8A3
|
solute carrier family 8 (sodium/calcium exchanger), member 3
|
|
SLC8B1
|
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNX17
|
sorting nexin 17
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SON
|
SON DNA binding protein
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SP1
|
Sp1 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPATA2
|
spermatogenesis associated 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRED3
|
sprouty-related, EVH1 domain containing 3
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SSFA2
|
sperm specific antigen 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAG1
|
stromal antigen 1
|
|
STAG2
|
stromal antigen 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STK11
|
serine/threonine kinase 11
|
|
STK16
|
serine/threonine kinase 16
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STK24
|
serine/threonine kinase 24
|
|
STK39
|
serine threonine kinase 39
|
|
STMN2
|
stathmin 2
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SYK
|
spleen tyrosine kinase
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TADA3
|
transcriptional adaptor 3
|
|
TAF7
|
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa
|
|
TBX5
|
T-box 5
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TICRR
|
TOPBP1-interacting checkpoint and replication regulator
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLN1
|
talin 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM109
|
transmembrane protein 109
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNPO1
|
transportin 1
|
|
TOB2
|
transducer of ERBB2, 2
|
|
TP53
|
tumor protein p53
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRANK1
|
tetratricopeptide repeat and ankyrin repeat containing 1
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTC1
|
tetratricopeptide repeat domain 1
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBG1
|
tubulin, gamma 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBA2
|
ubiquitin-like modifier activating enzyme 2
|
|
UBE2W
|
ubiquitin-conjugating enzyme E2W (putative)
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
UNC119
|
unc-119 homolog (C. elegans)
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP1
|
ubiquitin specific peptidase 1
|
|
USP6NL
|
USP6 N-terminal like
|
|
UTP14C
|
UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast)
|
|
VAMP4
|
vesicle-associated membrane protein 4
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCL
|
vinculin
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF2
|
WAS protein family, member 2
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDR48
|
WD repeat domain 48
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT2B
|
wingless-type MMTV integration site family, member 2B
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT9B
|
wingless-type MMTV integration site family, member 9B
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
XPO7
|
exportin 7
|
|
YAP1
|
Yes-associated protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZIC3
|
Zic family member 3
|
|
ZNF266
|
zinc finger protein 266
|
|
ZNF420
|
zinc finger protein 420
|
